09.05.2018 AlzChem Group AG  DE000A0AHT46

AlzChem Group AG: AlzChem research uncovers new synthesis route for amidines


 
DGAP-Media / 09.05.2018 / 16:52 AlzChem research uncovers new synthesis route for amidines Trostberg. Amidines are organic chemical compounds with an NCN structure, meaning a typical nitrogen-carbon-nitrogen sequence. These types of chemicals are one of AlzChem's core competencies. NCN structures are contained in many biologically active molecules, which is why a general new synthesis method is so important to the development and production of active ingredients in pharmaceuticals and crop protection. Amidines to this point have been difficult to synthesize, particularly without substituents on nitrogen. An alternative for these cases has now been uncovered: AlzChem research has found a new synthesis process for amidines that adds another innovative method to the toolbox of active ingredient chemistry. This new, previously unknown synthesis pathway developed from the foundation of AlzChem's intelligent combination of three areas of expertise - global technology leadership in NCN chemistry, decades of expertise in the synthesis of organomagnesium Grignard compounds and know-how in silane reactions: "Our innovative process will especially interest the pharmaceutical industry," explains Ulli Seibel, Chairman of the Management Board of AlzChem Group AG. "It also holds considerable potential for our growing Specialty Chemicals business segment, which already accounts for nearly 60 percent of our sales." The new method was published in the renowned scientific journal SYNLETT (Issue 2017; 28(12): 1437-1440); patents are pending. About AlzChem Group AG AlzChem Group AG is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The company has a leading position in select niche markets, including the markets for feed additives and food supplements. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,500 employees at four sites in Germany and three other sites abroad. End of Media Release --------------------------------------------------------------------------- Issuer: AlzChem Group AG Key word(s): Research/Technology 09.05.2018 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: AlzChem Group AG Dr.-Albert-Frank-Str. 32 83308 Trostberg Germany Phone: +498621862888 Fax: +49862186502888 E-mail: [email protected] Internet: www.alzchem.com ISIN: DE000A0AHT46 WKN: A0AHT4 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart End of News DGAP Media --------------------------------------------------------------------------- 684515 09.05.2018


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu AlzChem Group AG  ISIN: DE000A0AHT46 können Sie bei EQS abrufen


Beteiligungen , A0AHT4 , SFP1 , XETR:SFP1